The jury ruled that United States Surgical, a Covidien subsidiary, does not infringe Applied Medical’s US patent related to trocar seal technology.
Scott Flora, president of Surgical Devices, Covidien, said: “We are very pleased with the jury’s verdict and look forward to continuing to provide innovative surgical instruments to our customers.”